Management of opioid-induced constipation in palliative patients with disseminated cancer
DOI:
https://doi.org/10.12775/QS.2025.44.62828Keywords
palliative patients, constipation, cancer, opioid, laxatives, defecation, obstruction, PAMORA, naldemedineAbstract
Stool constipation is one of the most common afflictions affecting palliative patients with advanced cancer. The widespread use of opioids in the analgetic treatment of this group of patients exacerbates the already existing problem of constipation or is the underlying cause of its occurrence. Often, however, the etiology of the condition appears to be multifactorial. This article discusses the effects of opioids on the gastrointestinal tract as a cause of constipation, other possible causes of constipation in palliative patients, helpful definitions and how to diagnose constipation in this group of patients. Another important topic highlighted is the possibility of gastrointestinal obstruction and the possible management of its presence. Finally, the management of constipation is discussed, taking into account both non-pharmacological and pharmacological treatment with traditional laxatives and peripheral opioid receptor antagonists (naldemedine, naloxegol, methylnaltrexone). The article is based on an analysis of the available scientific literature and cited sources.
References
1.Leppert W, Dzierżanowski T, Stachowiak A, Ciałkowska-Rysz A, Pyszkowska J. Constipation in cancer patient - the management recommendations of the Expert Group of the Polish Association for Palliative Medicine. Palliative Medicine, 2014;6(3):117-126.
2.Dzierżanowski T, Jarosz J. Constipation in opioid-treated patients. Oncology in Clinical Practice, 2009;5(2):47-54.
3.Mesía R, Virizuela Echaburu JA, Gómez J, Sauri T, Serrano G, Pujol E. Opioid-Induced Constipation in Oncological Patients: New Strategies of Management. Curr Treat Options Oncol. 2019;20(12):91. doi: 10.1007/s11864-019-0686-6. PMID: 31853656; PMCID: PMC6920224.
4.Mari A, Mahamid M, Amara H, Baker FA, Yaccob A. Chronic Constipation in the Elderly Patient: Updates in Evaluation and Management. Korean J Fam Med. 2020;41(3):139-145. doi: 10.4082/kjfm.18.0182. PMID: 32062960; PMCID: PMC7272371.
5.Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scotté F, Ripamonti CI; ESMO Guidelines Committee. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv111-iv125. doi: 10.1093/annonc/mdy148. PMID: 30016389.
6.Kobiałka J, Ludwig B, Dziekiewicz J. Bystron J, Pathophysiology and management of opioid-induced constipation: a narrative review. Palliat Med Pract. 2023;17(4):233-244. doi: https://doi.org/10.5603/PMPI.a2023.0025
7.Leppert W, Dzierżanowski T, Ciałkowska-Rysz A, Jarosz J, Pyszkowska J, Stawchowiak A. The Management of Constipation in Palliative Medicine – Recommendations of the Expert Working Group of the Polish Association for Palliative Medicine. Palliative Medicine. 2009;1:1-10.
8.Dzierżanowski T. Jarosz J. Constipation in opioid-treated patients. Oncology in Clinical Practice. 2009;5(2):47-54.
9.Dave D., Ivyanskiy I., Naguib T., Overflow diarrhea and acute kidney injury as a presentation of fecal impaction that led to obstructive uropathy. MOJ Clinical and Medical Case Reports. 2021;11(3):71-74. DOI: 10.15406/mojcr.2021.11.00385
10.Kroser J. A., Metz D. C., Evaluation of the adult patient with diarrhea. Primary care: Clinics in Office Practice. 1996;23(3):629-647. DOI: 10.1016/s0095-4543(05)70352-3
11.Dzierżanowski T, Larkin P. Proposed Criteria for Constipation in Palliative Care Patients. A Multicenter Cohort Study. J Clin Med. 2021;10(1):40. doi: 10.3390/jcm10010040. PMID: 33375545; PMCID: PMC7795465.
12.Dzierżanowski T, The role of peripherally acting mu-opioid receptor antagonists (PAMORA) in the treatment of constipation in palliative care. Medycyna Paliatywna. 2019;11(2):51-57. doi: https://doi.org/10.5114/pm.2019.86528
13.Maruyama M, Kamimura K, Sugita M, et al. (2019) The Management of Constipation: Current Status and Future Prospects. Constipation. IntechOpen
14.Dzierżanowski T, Zając A, Ciałkowska-Rysz A, Filipczak-Bryniarska I, Graczyk M, Grądalski T, Janecki M. Constipation in palliative care patients - clinical practice guidelines. Medycyna Paliatywna. 2025,17(1);1-13. doi: https://doi.org/10.5114/mp.2025.148746
15.Bętkowska I. A., Żylicz Z. Emergencies in palliative care - clinical practice based on evidence. Palliative Medicine in Practice. 2017;11(4):153-165.
16.Bętkowska I., Grądalski T. Effectiveness of octreotide in advanced cancer patients with malignant bowel obstruction and intractable diarrhea. Advances in Palliative Medicine. 2009; 8(4):161-164.
17.Leppert W., Swoboda D. Management of cancer patients with symptoms of bowel obstruction. Palliative Medicine. 2010;4:177-189.
18.Madariaga A., Lau j., Ghoshal A., Dzierżanowski T., Larkin P., Sobocki J., Dickman A., Furness K., Fazelzad R., Crawford G. B., Lheureux S. MASCC multidisciplinary evidencebased recommendations for the management of malignant bowel obstruction in advanced cancer. Supportive Care in Cancer. 2022; 30(6):4711-4728. doi: 10.1007/s00520-022-06889-8
19.Faragher I. G., Chaitowitz I. M., Stupart D. A., Long-term results of palliative stenting or surgery for incurable obstructing colon cancer. Colorectal Disease. 2008;10(7):668-72. doi:10.1111/j.1463-1318.2007.01446.x
20.Vemulapalli R., Lara L.F., Sreenarasimhaiah j., Harford W. H., Siddiqui A. A., A Comparison of Palliative Stenting or Emergent Surgery for Obstructing Incurable Colon Cancer. Digestive Diseases and Sciences. 2010;55(6):1732-7. doi: 10.1007/s10620-009-0945-7.
21.Fiori E., Lamazza A., Schillaci A., Femia S., Demasi E., Decesare A., Sterpetti A. V. Palliative management for patients with subacute obstruction and stage IV unresectable rectosigmoid cancer: colostomy versus endoscopic stenting: fifinal results of a prospective randomized trial. The American journal of Surgery. 2012;204(3):321-6. doi: 10.1016/j.amjsurg.2011.11.013.
22.Corli O., Floriani I., Roberto A., Montanari M., Galli F., Greco M.T., Caraceni A., Kaasa S., Dragani T.A., Azzarello G., Luzzani M., Cavanna L., Bandieri E., Gamucci T., Lipar G., Di Gregorio R., Valenti D., Reale C., Pavesi L., Iorno L., Crispino C., Paccchioni M., Apolone G. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? Multicenter randomized phase 4 ‘real life’ trian on variability of response to opioids. Ann Oncol. 2016;27(6):1107-1115. doi: 10.1093/annonc/mdw097. PMID: 26940689.
23.Żylicz Z. Buprenorphine patches. A range of answers to nagging questions. Palliative Medicinie in Prctice. 2012;6(2):46-53
24.Mercadante S., Casuccio A., Tirelli W., Giarrattano A. Equipotent doses to switch from high doses of opioids to transdermal buprenorphine. Supportive Care in Cancer. 2009;12: 715-718. doi:10.1007/s00520-008-0546-6
25.Nosek K., Leppert W., Nosek H., Wordliczek J., Onichimowski D. Drug Design, Development and Therapy. 2017;11:2409–2419.DOI: 10.2147/DDDT.S141007
26.Staats P.S., Markowitz J., Schein J. Incidence of constipation associated with long-acting opioid therapy: a comparative study. 2004;97 (2):129-34. DOI: 10.1097/01.SMJ.0000109215.54052.D8
27.Dzierżanowski T, Ciałkowska-Rysz A. The influence of risk factors on occurrence in palliative care patients. Palliative Medicine. 2010;4:209-213.
28.McClurg D., Hagen S., Hawkins S., Lowe-Strong A. Abdominal massage for the alleviation of constipation symptoms in people with multiple sclerosis: a randomized controlled feasibility study. 2011;17(2): 223-33. DOI: 10.1177/1352458510384899
29.McClurg D., Hagen S., Jamieson K., Dickinson L., Paul L., Cunnington A. Abdominal massage for the alleviation of symptoms of constipation in people with Parkinson's: a randomised controlled pilot study. 2016;45(2):299-303. DOI: 10.1093/ageing/afw005
30.Squeo F, Celiberto F, Ierardi E, Russo F, Riezzo G, D'Attoma B, Di Leo A, Losurdo G. Opioid-induced Constipation: Old and New Concepts in Diagnosis and Treatment. J Neurogastroenterol Motil. 2024;30(2):131-142. doi: 10.5056/jnm23144
31.De Giorgio R, Zucco FM, Chiarioni G, Mercadante S, Corazziari ES, Caraceni A, Odetti P, Giusti R, Marinangeli F, Pinto C. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Adv Ther. 2021;38(7):3589-3621. doi: 10.1007/s12325-021-01766-y.
32.Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P. Laxatives for the management of constipation in people receiving palliative care. Cochrane Database Syst Rev. 2015;2015(5):CD003448. doi: 10.1002/14651858.CD003448.pub4.
33.Twycross R, Sykes N, Mihalyo M, Wilcock A. Stimulant laxatives and opioid-induced constipation. J Pain Symptom Manage. 2012; 43(2):306-313 doi: 10.1016/j.jpainsymman.2011.12.002.
34.Dzierżanowski T, The role of naldemedine in the treatment of opioid- induced constipation. Medycyna Paliatywna. 2020,12(4);167-173. doi: https://doi.org/10.5114/pm.2020.101700
35.Camilleri M, Lembo A, Katzka DA. Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits. Clin Gastroenterol Hepatol. 2017 ;15(9):1338-1349. doi: 10.1016/j.cgh.2017.05.014.
36.Kobiałka J, Ludwig B, Dziekiewicz J. Bystron J. Pathophysiology and management of opioid-induced constipation: a narrative review. Palliat Med Pract. 2023;17(4):233-244. doi: https://doi.org/10.5603/PMPI.a2023.0025
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Klaudia Zacher, Gabriela Prucnal, Karolina Ryba, Karolina Ochyra, Kornelia Pudło, Martyna Bukała, Katarzyna Znamirowska, Jowita Frydrych, Patrycja Walkiewicz, Anna Rakoczy
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 253
Number of citations: 0
